Helsinki - Delayed Quote EUR
Orion Oyj (ORNBV.HE)
53.55
+3.40
+(6.78%)
At close: 6:29:58 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,588,500
1,542,400
1,189,600
1,340,700
1,041,000
Cost of Revenue
610,900
596,000
531,900
489,000
447,500
Gross Profit
977,600
946,400
657,700
851,700
593,500
Operating Expense
541,200
531,800
392,500
415,400
355,800
Operating Income
436,400
414,600
265,200
436,300
237,700
Net Non Operating Interest Income Expense
-3,700
-3,800
-2,800
-800
-1,200
Pretax Income
435,000
413,100
271,900
440,300
242,300
Tax Provision
87,600
83,200
55,100
90,800
48,500
Net Income Common Stockholders
347,400
329,900
216,800
349,500
193,800
Diluted NI Available to Com Stockholders
347,400
329,900
216,800
349,500
193,800
Basic EPS
2.48
2.35
1.54
2.49
1.38
Diluted EPS
2.48
2.35
1.54
2.49
1.38
Basic Average Shares
140,512.76
140,476.40
140,326.68
140,501.28
140,546.56
Diluted Average Shares
140,563.88
140,532.67
140,361.04
140,589.74
140,563.90
Total Operating Income as Reported
--
416,600
274,900
439,600
243,300
Total Expenses
1,152,100
1,127,800
924,400
904,400
803,300
Net Income from Continuing & Discontinued Operation
347,400
329,900
216,800
349,500
193,800
Normalized Income
346,920.83
329,420.60
210,503.70
349,182.40
190,600
Interest Income
--
4,600
2,900
1,000
100
Interest Expense
--
7,600
5,200
1,500
1,000
Net Interest Income
-3,700
-3,800
-2,800
-800
-1,200
EBIT
442,500
420,700
277,100
441,800
243,300
EBITDA
442,500
513,500
328,700
489,300
289,100
Reconciled Cost of Revenue
610,900
596,000
531,900
489,000
447,500
Reconciled Depreciation
--
92,800
51,600
47,500
45,800
Net Income from Continuing Operation Net Minority Interest
347,400
329,900
216,800
349,500
193,800
Total Unusual Items Excluding Goodwill
600
600
7,900
400
4,000
Total Unusual Items
600
600
7,900
400
4,000
Normalized EBITDA
441,900
512,900
320,800
488,900
285,100
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
120.83
120.60
1,603.70
82.40
800
12/31/2021 - 10/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AZN.ST AstraZeneca PLC
1,337.00
+0.94%
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
AMGN.MX Amgen Inc.
5,500.00
0.00%
4AB.F AbbVie Inc.
155.80
+0.65%
OPHLY Ono Pharmaceutical Co., Ltd.
3.9000
-0.51%
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.98
+3.10%
ZEG.DE AstraZeneca PLC
122.30
+1.03%
NOV.MU Novo Nordisk A/S
55.01
+1.05%
GRF-P.MC Grifols SA
6.41
+0.16%
0R34.IL Johnson & Johnson
155.60
-1.46%